I like DVAX but I can't figure out that clinical hold on their Hep B drug, Heplislav. Can they get around that severe adverse event? I like how the drug is more effective in less doses and it will jump if they can get past the clinical hold. Here are links to the hold and adverse event.
Market Data 
Markets 
AI
